Cite
HARVARD Citation
Gebeyehu, G. et al. (n.d.). P596 Ustekinumab and anti-TNF agents are equally safe and effective in elderly Crohn's disease patients: A propensity adjusted multi-centre cohort study. Journal of Crohn's and colitis. pp. i723-i724. [Online].